Last reviewed · How we verify
Pioglitazone and metformin and insulin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Pioglitazone and metformin and insulin (Pioglitazone and metformin and insulin) — Takeda.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pioglitazone and metformin and insulin TARGET | Pioglitazone and metformin and insulin | Takeda | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pioglitazone and metformin and insulin CI watch — RSS
- Pioglitazone and metformin and insulin CI watch — Atom
- Pioglitazone and metformin and insulin CI watch — JSON
- Pioglitazone and metformin and insulin alone — RSS
Cite this brief
Drug Landscape (2026). Pioglitazone and metformin and insulin — Competitive Intelligence Brief. https://druglandscape.com/ci/pioglitazone-and-metformin-and-insulin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab